Insulin Pricing, PBM Relationships Under Government Microscope

Minnesota Attorney General demands Novo Nordisk and Sanofi provide information on their insulin pricing; they are also among several companies facing probes over their contracts with pharmacy benefit managers.

insulin hormone vials-single use syringe_1200x675

More from Pricing Debate

More from Market Access